Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination serotonin specific reuptake inhibitor and serotonin 1A receptor partial agonist for reducing L-DOPA-induced dyskinesia

Combination serotonin specific reuptake inhibitor and serotonin 1A receptor partial agonist for reducing L-DOPA-induced dyskinesia

US Patent 12285426 · Granted Apr 29, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants2024
HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants2021
Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson2018
Antibodies targeting HIV escape mutants2018
Chemiluminescence proximity nucleic acid assay2014
Chemiluminescence proximity nucleic acid assay2012
Bifurcated graft with an inferior extension2011
Bifurcated graft with a superior extension2005
Bifurcated graft with a superior extension2003
Graft with multiple channels2003
Bifurcated graft with a superior extension2002
Modular bifurcated intraluminal grafts and methods for delivering and assembling2002